Apr. 26 at 8:51 PM
$AVR
Key Advantages of Anteris DurAVR
Comparative analyses presented in 2026 highlight specific areas where the DurAVR may outperform the SAPIEN 3:
Superior Hemodynamics: The DurAVR has demonstrated significantly lower mean pressure gradients and larger effective orifice areas (EOA) compared to the SAPIEN 3. This is largely due to its unique 3D single-piece tissue design, which allows for a more complete valve opening.
Anteris Technologies
Anteris Technologies
+3
Restoration of Laminar Flow: Unlike traditional bioprosthetic valves that often create turbulent flow, the DurAVR is designed to restore healthy laminar (straight) flow. Cardiac MRI data has shown that post-implantation flow patterns closely resemble those of a healthy native valve.
Anteris Technologies
Anteris Technologies
+1
Reduced Patient-Prosthesis Mismatch (PPM): In patients with small aortic annuli (area ≤ 430 mm²), the DurAVR was associated with a 98.5% freedom from moderate or severe PPM, which is significant.
